YOU want to gain in efficiency in your screening

Relevant models are crucial for multi-target and multicellular diseases (e.g. cancer and neurodegenerative diseases).

WE believe in phenotypic screening as the answer

Because phenotypic screening is a global approach on cells and is performed by High Content Screening (HCS)

HCS Pharma is YOUR partner to implement HCS in your drug discovery

According to your needs, we support you or do it for you!

Services

Explain us your requirements and we develop your assays to best meet your needs !

More
Sweetch Energy lève 1,4 million d’euros pour produire de l’électricité à partir d’eau salée

Team

Want to know who we are ?

More
Sweetch Energy lève 1,4 million d’euros pour produire de l’électricité à partir d’eau salée

Why HCS ?

To target complex diseases (as cancer and neurodegenerative diseases), more than one target are needed and screening on complex model is recommended.

More
Sweetch Energy lève 1,4 million d’euros pour produire de l’électricité à partir d’eau salée

Contact Us

A question ? A comment ? Feel free to contact us !

More
Sweetch Energy lève 1,4 million d’euros pour produire de l’électricité à partir d’eau salée

Our Services

Latest Post

Sweetch Energy lève 1,4 million d’euros pour produire de l’électricité à partir d’eau salée

Nouveaux voisins au Biopole de Rennes

+english

22nd May 2017

More

Eurasanté in the “15 Best Biotech Incubators” of labiotech.eu

We entered the incubator one year ago !

B°Ker sécurise le fonctionnement des laboratoires

B°Ker protège les installations de laboratoire

+english

18th May 2017

More

A “drug discovery” course on Coursera

A overview of this changing landscape !

+HCS, HCA & Biology

16th May 2017

More

Deep Learning: An AI-Driven Genomics Company Is Turning to Drugs

A new era of information-based medicine

+francais

10th May 2017

More

Du Deep Learning pour aider au dépistage du cancer du poumon

Deep Learning et Imagerie pour dépister le cancer

+english

03rd May 2017

More

HCS Pharma at Advances in Cell Based Screening in May 10 & 11

Curious about our toxicology and phenotypic screening services ?

+english

02nd May 2017

More

A great Molecular Devices user meeting in Cambridge !

InnovCell 3D, Chopin and a lot of 3D segmentation !

+english

28th Apr 2017

More

Poster – Neurotoxicity assay on 2D and 3D culture using High Content Screening (HCS) technology

As shown by AstraZeneca in nature reviews*, one third of safety failures along the drug discovery process is linked...

+francais

24th Apr 2017

More

Le site du projet CHOPIN est en ligne

Découvrez l'actualité de ce projet en ligne

+english

20th Apr 2017

More

Promissing encounters at in-cosmetics Global London

How cellular imaging and image analysis can be used !

+english

18th Apr 2017

More

Great conference on DYRK1A and related kinases and human disease !

We were in Saint Malo for the first meeting on DYRKs related disease

+english

13th Apr 2017

More

Precision Medicine, the good way to cure complexe diseases

Precision medicine is a new step in healthcare

+english

11th Apr 2017

More

It’s done, our laboratories in Lille Metropole are under construction !

Work began in our future laboratories

+english

10th Apr 2017

More

Meet us at « High-Content and Phenotypic Screening » in Cambridge

We will talk about advantages of 3D culture in phenotypic screening

+english

07th Apr 2017

More

Our vision of the future of laboratories at Forum LABO 2017 Paris

Deep Learning, Augmented and Virtual Realities could change the laboratory

+english

03rd Apr 2017

More

HCS Pharma at in-cosmetics Global in London

Julian, our COO, will attend in-cosmetics Global in London

+english

31st Mar 2017

More

Poster – In vitro dermocosmetology : high content analysis approach using human primary keratinocytes and fibroblasts

Our poster

+francais

30th Mar 2017

More

Création du label « France HealthTech »

France eHealthTech est un label du ministère français des affaires étrangères

+english

28th Mar 2017

More

DNA typos might be the main cause of genetic mutations occurs in cancer

A controversial study about links between tumors and genetic mutations